Advancements in prognostication tools in MPNs in recent years

In this video, Lindsay Rein, MD, Duke University Medical Center, Durham, NC, briefly comments on the recent advancements in the development of prognostic tools for clinicians to use when treating patients with myeloproliferative neoplasms (MPN) to allow for optimal selection and timing of therapy. This interview took place at the 29th Congress of the European Hematology Association (EHA) in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.